Oslo Cancer Cluster shared a post on LinkedIn:
“Big thanks to everyone who attended the Cell Therapy Innovation Symposium 2025!
Hosted by Thermo Fisher Scientific and Oslo Cancer Cluster in collaboration with the CellFit Project, the event was packed with scientists and industry leaders tackling the future of immune cell therapy manufacturing.
Missed the event? Read more here.”
Fredrik Schjesvold, Head of Oslo Myeloma Center at Oslo University Hospital, shared a post by Oslo Cancer Cluster, adding:
“Especially interesting to hear about the experience with academic CAR-Ts in Spain.”